Family Legacy Inc. Buys 121 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Family Legacy Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,946 shares of the healthcare conglomerate’s stock after purchasing an additional 121 shares during the period. UnitedHealth Group makes up approximately 1.4% of Family Legacy Inc.’s investment portfolio, making the stock its 28th biggest position. Family Legacy Inc.’s holdings in UnitedHealth Group were worth $4,168,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in UNH. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $341,000. Principal Financial Group Inc. increased its stake in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. Edgestream Partners L.P. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $4,522,000. Cobblestone Capital Advisors LLC NY increased its position in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Cobblestone Capital Advisors LLC NY now owns 3,476 shares of the healthcare conglomerate’s stock valued at $2,032,000 after purchasing an additional 33 shares during the last quarter. Finally, Bellevue Group AG lifted its position in UnitedHealth Group by 9.7% in the third quarter. Bellevue Group AG now owns 225,550 shares of the healthcare conglomerate’s stock worth $131,875,000 after buying an additional 19,875 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.0 %

Shares of NYSE:UNH opened at $515.47 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The business’s 50-day moving average is $508.81 and its 200 day moving average is $543.92. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

UNH has been the subject of several analyst reports. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.